AvidBiotics Corp.

Following on from the early December announcement that it is paying $3bn for US gene therapy company Audentes Therapeutics Inc. , Astellas Pharma Inc. has bought the privately held US immuno-oncolo

Much of modern medicine since the Middle Ages was born out of the fight against harmful bacteria – the so-called germ theory of disease. Now, though, a growing number of scientists believe bacteria ma

AvidBiotics Corp. ’s Avidocin proteins are engineered to target a single bacterium strain without collateral damage. The proteins – tweaked versions of R-type bacteriocins, or naturally occurring d

It's official: fighting antibiotic-resistant bacteria is now a national security priority for the US. On September 18, 2014, President Barack Obama issued an executive order requiring the National Sec